CC Q1 2026 Earnings Strong EPS Surprise Despite Unreported Revenue NRDY Q1 2026 Earnings EPS Beat of 858 Fails to Lift Stock GAIA Q1 2026 Earnings EPS Misses Estimate Amid Flat Revenue Visibility Forte Biosciences Q1 2026 Earnings Prerevenue Biotech Misses EPS Estimates Stock Dips on Narrower Loss Miss Teradyne Q1 2026 Earnings Strong EPS Beat Driven by Robust Demand in Semiconductor Test INBS Q1 2025 Earnings EPS Misses Estimates as Company Reports No Revenue